Maksin Arisandi - PT Gudang Head Affairs
| GGNPF Stock | USD 1.14 0.00 0.00% |
Insider
Maksin Arisandi is Head Affairs of PT Gudang Garam
| Phone | 62 35 468 2091 |
| Web | https://www.gudanggaramtbk.com |
PT Gudang Management Efficiency
The company has return on total asset (ROA) of 0.0312 % which means that it generated a profit of $0.0312 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.052 %, meaning that it generated $0.052 on every $100 dollars invested by stockholders. PT Gudang's management efficiency ratios could be used to measure how well PT Gudang manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Sierk Poetting | BioNTech SE | 51 | |
| Karen Anderson | Centessa Pharmaceuticals PLC | 56 | |
| BS CPA | Inhibrx | 42 | |
| Thomas Templeman | Centessa Pharmaceuticals PLC | 64 | |
| M MD | Lipocine | 66 | |
| Logan Morse | Lipocine | 54 | |
| Joshua MBA | Centessa Pharmaceuticals PLC | 50 | |
| Jens Holstein | BioNTech SE | 61 | |
| CPA CPA | Lipocine | 54 | |
| Tia Bush | Centessa Pharmaceuticals PLC | 53 | |
| Iqbal LLB | Centessa Pharmaceuticals PLC | 43 | |
| Mark Lappe | Inhibrx | 57 | |
| MD MSc | Centessa Pharmaceuticals PLC | 64 | |
| David Grainger | Centessa Pharmaceuticals PLC | 55 | |
| David Chao | Centessa Pharmaceuticals PLC | 56 | |
| Michael Boehler | BioNTech SE | N/A | |
| John Moran | Dream Finders Homes | N/A | |
| Ryan Richardson | BioNTech SE | 45 | |
| Quinn Deveraux | Inhibrx | N/A | |
| Ozlem MD | BioNTech SE | 57 | |
| Ringo Tsang | Highway Holdings Limited | 58 | |
Management Performance
| Return On Equity | 0.052 | |||
| Return On Asset | 0.0312 |
PT Gudang Garam Leadership Team
Elected by the shareholders, the PT Gudang's board of directors comprises two types of representatives: PT Gudang inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GGNPF. The board's role is to monitor PT Gudang's management team and ensure that shareholders' interests are well served. PT Gudang's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PT Gudang's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Patricius Setianto, Head HR | ||
| Susilo Wonowidjojo, Pres Director | ||
| Paolo Zulian, Head Engineering | ||
| Indra W, Chief Officer | ||
| Freedy, Head Division | ||
| A Setyo, Head Cigarettes | ||
| Maksin Arisandi, Head Affairs | ||
| Agus P, Head Cigarettes | ||
| Lusia Erlinawati, Head Division | ||
| Suwardi, Head Unit |
GGNPF Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is PT Gudang a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.052 | |||
| Return On Asset | 0.0312 | |||
| Profit Margin | 0.02 % | |||
| Current Valuation | 2.18 B | |||
| Shares Outstanding | 1.92 B | |||
| Shares Owned By Insiders | 76.27 % | |||
| Shares Owned By Institutions | 2.57 % | |||
| Price To Earning | 5.39 X | |||
| Price To Book | 0.85 X | |||
| Price To Sales | 0.38 X |
Currently Active Assets on Macroaxis
Other Information on Investing in GGNPF Pink Sheet
PT Gudang financial ratios help investors to determine whether GGNPF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GGNPF with respect to the benefits of owning PT Gudang security.